APPLICATION OF ALPHA-1-ANTITRYPSIN FOR PREPARING DRUG FOR TREATING CHRONIC FATIGUE SYNDROME Russian patent published in 2011 - IPC A61K38/57 A61P25/00 A61P43/00 

Abstract RU 2436590 C1

FIELD: medicine, pharmaceutics.

SUBSTANCE: application of alpha-1-antitrypsin (AAT) for preparing a drug for treating chronic fatigue syndrome (CFS) is offered. It is shown: AAT inhibited intracellular elastase activity of mononuclear cells of peripheral blood of the CFS patients, prevented degradation RNAase L 83 kDa with formation of the overactive RNAase L 37 kDa form. After treating with the preparation AAT, elastase activity in the specified blood cells decreased from approximately 1459 U/mg to 134 U/mg; the patient showed obvious clinical improvements, decreased cognitive disorders cognitive infringements, has went back to work. Particularly, the invention refers to the application of plasma or other therapeutic forms containing alpha-1-antitrypsin sufficient for produce a dosage of alpha-1-antitrypsin equal to 6 mg or more per one kg of body weight with frequency 1 to 31 days.

EFFECT: higher clinical effectiveness.

4 cl

Similar patents RU2436590C1

Title Year Author Number
DIAGNOSTIC TECHNIQUE FOR ASTHENIC SYNDROME IN SCHIZOPHRENIC PATIENTS 2019
  • Klyushnik Tatyana Pavlovna
  • Smulevich Anatolij Boleslavovich
  • Zozulya Svetlana Aleksandrovna
  • Simonov Anatolij Nikiforovich
  • Olejchik Igor Valentinovich
  • Yakimets Anna Vladimirovna
  • Voronova Evgeniya Ivanovna
  • Ivanov Stanislav Viktorovich
  • Kharkova Galina Sergeevna
RU2709105C1
ALPHA-1-ANTITRYPSIN (AAT) IN TREATMENT AND (OR) PREVENTION OF NEUROLOGICAL DISORDERS 2022
  • Zhukovskij, Nikolaj
RU2840475C2
TREATMENT AND/OR PREVENTION OF DISEASE OR SYNDROME ASSOCIATED WITH VIRAL INFECTION 2021
  • Zhukovsky Nikolay
RU2823437C2
METHODS OF PRODUCING AND USING RECOMBINANT ALPHA-1-ANTITRYPSIN (AAT) AND COMPOSITIONS BASED THEREON 2020
  • Vurm, Mariya Zhoao
  • Vurm, Florian Mariya
  • Yanchauskine, Sabina
  • Khamakher, Yurg
  • Shtammberger, Uts
RU2817416C2
COMPOSITIONS AND METHODS FOR TREATMENT OF LUNG EMPHYSEMA AND OTHER FORMS OF COPD 2019
  • Yanssen, Rob
RU2789128C2
METHOD OF PREDICTIVE DIAGNOSTICS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2022
  • Kobylyanskij Vyacheslav Ivanovich
RU2814535C1
METHOD FOR REHABILITATION OF PATIENTS WITH CHRONIC FATIGUE SYNDROME AFTER SUFFERING CORONAVIRUS INFECTION ON BASIS OF PEPTIDE BIOREGULATORS USING SUBLINGUAL SPRAY 2024
  • Achkasov Evgenii Evgenevich
  • Gromov Aleksei Vladimirovich
RU2839802C1
FUSION SERPINE POLYPEPTIDES AND METHODS FOR THEIR APPLICATION 2012
  • Ekkelman Brendan P.
  • Timmer Dzhon S.
  • Ngui Piter L.
  • Gyunter Grant B.
  • Devero Kuinn
RU2642310C2
FUSED SERPIN POLYPEPTIDES AND METHODS FOR USE THEREOF 2012
  • Ekkelman, Brendan, P.
  • Timmer, Dzhon, S.
  • Ngui, Piter, L.
  • Gyunter, Grant, B.
  • Devero, Kuinn
RU2727452C1
ALPHA-1-ANTITRYPSIN FOR TREATING EPISODES OF PULMONARY DISEASE AGGRAVATIONS 2007
  • Bauehr Shabtaj
RU2472524C2

RU 2 436 590 C1

Authors

Garsija Kintana Ana

Alegre Martin Khose

Dates

2011-12-20Published

2010-06-29Filed